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Abstract 
Prolyl-4-hydroxylation is necessary for proper structural assembly of collagens and oxygen-
dependent protein stability of hypoxia-inducible transcription factors (HIFs). In vitro function of 
HIF prolyl-4-hydroxylase domain (PHD) enzymes requires oxygen and 2-oxoglutarate as co-
substrates with iron (II) and vitamin C serving as co-factors. While vitamin C deficiency is 
known to cause the collagen-disassembly disease scurvy, it is unclear whether cellular oxygen 
sensing is similarly affected. Here we report that vitamin C deprived Gulo-/- knock-out mice 
show normal HIF-dependent gene expression. The systemic response of Gulo-/- animals to 
inspiratory hypoxia, as measured by plasma erythropoietin levels, was similar to animals 
supplemented with vitamin C. Hypoxic HIF induction was also essentially normal under serum- 
and vitamin C-free cell culture conditions, suggesting that vitamin C is not required for oxygen 
sensing in vivo. Glutathione was found to fully substitute for vitamin C requirement of all three 
PHD isoforms in vitro. Consistently, glutathione also reduced HIF-1α protein levels, 
transactivation activity and endogenous target gene expression in cells exposed to CoCl2. A 
C201S mutation in PHD2 increased basal hydroxylation rates and conferred resistance to 
oxidative damage in vitro, suggesting that this surface accessible PHD2 cysteine residue is a 
target of antioxidative protection by vitamin C and glutathione. 
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Introduction 
Oxygen is essential for a number of physiological processes, particularly for cellular 
respiration and energy metabolism. On the molecular level, response to hypoxia is mediated by 
hypoxia-inducible transcription factors termed HIFs. Under continuous oxygen supply, two 
distinct prolyl residues within the oxygen-dependent degradation domain (ODD) of HIFα 
subunits are hydroxylated by prolyl-4-hydroxylase domain-containing enzymes (PHDs). 
Hydroxy-HIFα is recognized by the von Hippel-Lindau tumor suppressor protein (pVHL) and 
subsequently targeted for proteasomal degradation 1,2. When oxygen is limited, PHD activity 
ceases, non-hydroxylated HIFα is stabilized and heterodimerizes with the HIFβ subunit to 
activate expression of numerous target genes 3. Moreover, an asparaginyl hydroxylase termed 
factor inhibiting HIF (FIH) hydroxylates a C-terminal Asn residue of HIF-α subunits in an 
oxygen-dependent manner, thereby regulation co-factor recruitment and HIF’s transcriptional 
activity 4.  
 Three PHD isoforms have been characterized so far, termed PHD1, PHD2 and PHD3, 
which differ in size, subcellular localization and tissue distribution 5. PHD2 is the most 
ubiquitously expressed isoform, responsible for the normoxic control of HIFα 6. Accordingly, 
genetic ablation of PHD2 but not PHD1 or PHD3 results in embryonic lethality in mice 7. 
Suggesting a fundamental role in the hematopoietic and circulatory systems, somatic inactivation 
of PHD2 leads to increased erythropoiesis and angiogenesis as a result of HIFα stabilization 
followed by activation of its target genes, including erythropoietin (EPO) and vascular 
endothelial growth factor (VEGF) 8. Knock-out of either PHD1 or PHD3 had no effect on 
hematological parameters. However, combined PHD1/PHD3 knock-out animals showed a slight 
increase in hematocrit, hemoglobin and red blood cell counts 9. Clinical data on patients with 
erythrocytosis revealed P317R or R371H mutations in the gene encoding for PHD2, altering the 
hydroxylation efficiency of the mutant protein 10,11. A third point mutation in PHD2 (H374R) 
was found in a patient suffering from erythrocytosis and paraganglioma 12. These case reports 
emphasize the critical role of PHD2 in regulating erythropoiesis and maintaining red blood cell 
homeostasis also in humans. 
 PHDs belong to a larger superfamily of 2-oxoglutarate and Fe (II)-dependent di-
oxygenases. Similar to collagen prolyl-4-hydroxylase (C-P4H, EC 1.14.11.2), PHDs require 
molecular oxygen and 2-oxoglutarate as co-substrates, as well as ferrous iron and probably 
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vitamin C as co-factors for enzymatic activity 13. Km-values of PHDs for oxygen are strikingly 
higher than those of other prolyl-4-hydroxylases 13. The relatively low oxygen affinity is 
essential for effective oxygen sensing, since even small changes in oxygen partial pressure can 
influence hydroxylation activity 13-15.  
 In a previous study we reported on the dose-dependent regulation of the in vitro activity 
of all three PHD isoforms by their essential co-substrates and co-factors, including vitamin C 16. 
Primates, including humans, lost the ability to de novo synthesize vitamin C and thus depend on 
dietary vitamin C intake. Since ascorbate is an essential co-factor for C-P4Hs which hydroxylate 
proline residues to stabilize the collagen triple helix structure, persistent ascorbate deficiency 
results in disassembly of connective tissue structures, a common symptom of the nowadays rare 
disease scurvy 17. With Km-values ranging from 140-180 μM, the requirement of PHDs for 
vitamin C in vitro is only two fold lower than for C-P4H, suggesting that also HIF hydroxylases 
could well be affected by vitamin C malnutrition 13. Mice lacking a functional Gulo gene have 
been described as a model to study vitamin C deficiency 18. Gulo encodes for L-gulono-1,4-
lactone-oxidase (GLO, EC 1.1.3.8), a key enzyme involved in the final step of L-ascorbic acid 
(vitamin C) biosynthesis. Dietary vitamin C deprivation leads to body weight loss, anemia, aortic 
wall damage and internal hemorrhages in these mice 18.  
 While the interaction between the target prolyl residue, molecular oxygen, 2-oxoglutarate 
and iron during the reaction cycle in the active center of PHDs has been described in detail, the 
apparently inevitable presence of vitamin C for the in vitro function of the PHDs remains elusive 
19,20
. Due to its antioxidative properties, vitamin C might maintain ferrous iron in the reduced 
state. Given the enzymatic relationship between HIFα and collagen prolyl-4-hydroxylases, we 
set out to investigate the effect of dietary vitamin C on the regulation of the PHD-HIF oxygen 
sensing pathway in Gulo-/- mice under normoxaemic and hypoxaemic conditions. 
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Methods 
Cell culture. HeLa human cervix carcinoma cells were adapted to Ham´s Nutrient 
Mixture F12 (Sigma), free of ascorbate and FCS, containing the following supplements: EGF (50 
ng/ml, Sigma), insulin (5 μg/ml, Sigma), apo-transferrin (5 μg/ml, Sigma), hydrocortisone (100 
nM, Sigma) buffered with 15 mM Hepes (pH 7.4) as well as 100 IU/ml penicillin and 100 μg/ml 
streptomycin. HepG2 human hepatoma cells stably transfected with a HIF-dependent firefly 
luciferase reporter gene termed HRG1 have been described before 21. If not indicated otherwise, 
all cells were maintained in Dulbecco's Modified Eagle Medium with 10% FCS, 100 IU/ml 
penicillin and 100 μg/ml streptomycin. Cell number and viability was determined using a ViCell 
Counter (Beckman). 
 
HIF transactivation activity. 5×105 HeLa cells were co-transfected with 500 ng of the 
HIF-dependent pH3SVL reporter vector containing a total of 6 HIF binding sites derived from 
regulatory elements of the transferrin gene 22 and 40 ng of pRL-CMV Renilla luciferase 
expression plasmid (Promega) essentially as described before 14. 24 hours post transfection, cells 
were split and exposed to graded oxygen concentrations (21%-0.2% oxygen) for 24 hours using 
cross-calibrated oxygen-controlled CO2 incubators (Binder CB 150). Stably transfected HRG1 
HIF reporter cells were adapted to 1% FCS overnight and treated with 50 μM desferrioxamine 
mesylate (Dfx, Sigma) or 100 µM CoCl2 and 1-10 mM reduced glutathione (GSH, 250 mM 
stock solution adjusted to pH 7.0) or 0.2-2 mM ascorbate for 24 hours. For hypoxic experiments, 
cells were grown under 2% O2 for 24 hours and treated with GSH or ascorbate. HRG1 cells were 
transfected with pRL-SV40 Renilla luciferase to control for non-HIF mediated effects of 
ascorbate and GSH on the heterologous SV40 minimal promoter present in both constructs. Cells 
were lysed using passive lysis buffer and luciferase activities were determined according to the 
manufacturer's instructions (Promega) using a 96-well luminometer (Berthold). Data are 
expressed as relative luciferase activities per total cellular protein of experiments performed in 
triplicates by calculating the ratio of firefly/renilla activities per well. 
 
Expression and purification of recombinant PHD enzymes. Recombinant PHD 
proteins were expressed and purified as glutathione-S-transferase (GST)-fusion proteins from 
baculovirus-infected Sf9 insect cells as described earlier 14. Untagged enzyme preparations were 
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obtained by introducing a PreScission protease cleavage site between the GST-tag and the PHD 
open reading frame. A C201S point mutation was introduced into the human PHD2 expression 
plasmid by site-directed mutagenesis (Stratagene). Untagged PHD2 was expressed in Sf9 cells 
and purified by conventional ion-exchange chromatography (kind gift of Dr. Felix Oehme, Bayer 
Healthcare, Wuppertal, Germany). Purity of the enzyme preparations was analyzed by SDS-
PAGE followed by Coomassie staining or immunoblotting. 
 
Prolyl-4-hydroxylation assay. Activity of recombinant PHD enzymes was measured by 
a microtiter plate-based peptide hydroxylation assay as described before 23. Briefly, recombinant 
PHDs were used to hydroxylate a biotinylated peptide derived from HIF-1α (amino acid residues 
556 to 574) coupled to streptavidin-coated 96-well plates. Hydroxylation reaction was performed 
for 1 hour at room temperature in the presence of 10 μM FeSO4, 0.5 mM 2-oxoglutarate and 2 
mM ascorbate in 20 mM Tris-HCl pH 7.5, 5 mM KCl and 1.5 mM MgCl2. Hydroxylated 
peptides were detected by recombinant, thioredoxin-tagged von Hippel-Lindau/elongin 
B/elongin C (VBC) complex. Reactions were stopped by removing the reaction mix and adding 
1 mM H2O2. Bound VBC complex was detected by rabbit anti-thioredoxin antibodies and 
secondary HRP-conjugated anti-rabbit antibodies (Sigma) using the 3,3,5,5-tetramethylbenzidine 
substrate kit (Pierce). The peroxidase reaction was stopped by adding 2 M H2SO4 and 
absorbance was determined at 450 nm in a microplate reader. Background values as determined 
by using a mutant HIF-1α (P564A) peptide were subtracted for each experiment. 
 
Ascorbate determination. Ascorbate content of in vitro hydroxylation assay samples 
was quantified by HPLC as described before 24. Briefly, a 10-fold dilution of the enzyme 
reaction mix containing 2 mM ascorbate was analyzed before and after 1 hour of hydroxylation 
reaction. Following dilution in the mobile phase (60 mM phosphoric acid, pH 3.1), a 20 μl 
sample was injected onto a Nucleosil C18 column and eluted applying an acetonitrile gradient 
(0-60%). Ascorbate elution was monitored at 254 nm, corresponding to 96% absorbance of 
ascorbate and only 4% of dehydroascorbate 25. Chromatograms and standard curve of pure 
ascorbate ranging from 25-200 μM were used to calculate the content of ascorbate in study 
samples (Supplementary Fig. 2). Ascorbate levels in plasma samples of mice were determined by 
HPLC (Swiss Vitamin Institute, Epalinges, Switzerland). 
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Immunoblot analyses. Total soluble cellular proteins were extracted with a high salt 
extraction buffer containing 0.4 Μ NaCl, 0.1% Nonidet P-40, 10 mΜ Tris-HCl (pH 8.0), 1 mΜ 
EDTA, 1 mM dithiothreitol, 1 mΜ phenylmethylsulfonyl fluoride and protease inhibitor cocktail 
(Sigma). Protein concentration was measured by the method of Bradford and 60-70 μg of cellular 
protein was subjected to immunoblot analyses. Membranes were probed using the following 
dilutions of mouse monoclonal (mAb) or rabbit polyclonal antibodies: mAb anti-HIF-1α (BD 
Transduction Laboratories, 1:1000), mAb anti-CA9 (M75, kindly provided by S. Pastorekova, 
Bratislava, Slovak Republic), mAb anti-β-actin (Sigma, 1:5000), rabbit anti-PHD1 (Genway, 
1:2000), rabbit anti-PHD2 (Novus, 1:1000) or rabbit anti-PHD3 (Novus, 1:1000), followed by 
secondary HRP-conjugated antibodies (all Pierce, 1:2000). 
 
mRNA quantification. Total RNA purification and mRNA determination by real-time 
PCR has been described before 14. Transcript levels of the HIF-dependent and -independent 
genes were quantified by reverse transcription (RT) quantitative (q) PCR using SybrGreen qPCR 
reagent kit (Sigma) in combination with an MX3000P light cycler (Stratagene). Initial copy 
number of each sample was calculated by comparison with serial dilutions of a calibrated 
standard. For mouse tissues, ribosomal protein S12 mRNA was used as a housekeeping gene 
while ribosomal protein L28 mRNA served as control for samples from human cell lines. Primer 
sequences are given in Supplementary Table 1. 
 
Oxyblot detection of protein oxidation. PHD2 carbonylation was determined with a 
protein oxidation detection kit (Oxyblot, Millipore). Briefly, 50 ng/μl of recombinant PHD2 was 
exposed to either 100 μM CoCl2, 10 μM FeSO4, 2 mM ascorbate, 0.5 mM 2-oxoglutarate or 1 
mM H2O2 in the presence of 400 nM wild-type or P564A mutant HIF-1α peptide in 20 mM Tris-
Cl, 5 mM KCl and 1.5 mM MgCl2 for 1 hour at room temperature. Five μl of the reaction mix 
were mixed with 5 μl 12% SDS and carbonyl groups were derivatized with 10 mM 2,4-
dinitrophenylhydrazine (DNPH) for 15 minutes. DNP groups were detected by immunoblotting 
using rabbit anti-DNP antibodies (1:150) followed by secondary goat anti-rabbit HRP-
conjugated antibodies (1:300). For loading controls, PHD2 was detected using rabbit anti-PHD2 
antibodies (Novus).  
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Animal studies. Gulo-/- mice were maintained on vitamin C–supplemented water 
containing 0.33 g/L of L-ascorbic acid and 0.01 mM EDTA as described earlier 18. At 3 months 
of age, ascorbic acid supplement was withdrawn from six Gulo-/- males while continued for the 
control males. After 5 weeks, mice were killed with an overdose of 2,2,2-tribromoethanol, and 
tissues were collected and stored in RNAlater (Applied Biosystems Inc, Foster City, CA) at -
20oC until use. For hypoxia studies, 22 Gulo-/- males with an average age of 16 weeks were 
allocated to four groups so that no significant changes were observed in mean body weight and 
age of the animals at the beginning of the experiment. The body weight was determined every 
second day. After 36 days of ascorbate withdrawal, mice were exposed to 8% oxygen for 24 
hours in a hypoxia tent (Coy Laboratory Products Inc.). Control animals were maintained at 
ambient oxygen concentration. Heparinized whole blood was collected from all mice by cardiac 
puncture after intraperitoneal injection anaesthesia using 4 mg/ml xylazine and 20 mg/ml 
ketamine at a dosage of 0.1 ml/20 g of body weight. Blood samples of hypoxic animals were 
collected inside the hypoxic tent. Animal experiments were conducted at two centers with the 
appropriate consent by the Institutional Animal Care and Use Committees of the University of 
North Carolina–Chapel Hill for breeding and normoxic gene expression studies or the Veterinary 
Office of the Canton Zürich (119/2010) for hypoxia studies, respectively. 
 
Blood parameters and plasma EPO concentrations. Plasma EPO levels were 
measured by ELISA following the procedures recommended by the manufacturer (Quantikine, 
R&D Systems). EPO concentrations were determined by comparison to a calibrated recombinant 
mouse EPO standard. Hematologic parameters of mouse whole blood were analyzed by the 
Division of Hematology (University Hospital, Zürich, Switzerland). 
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Results 
Ascorbate is not required for HIF induction by hypoxia in HeLa cells. HeLa cells 
have been described previously to grow in serum-free medium supplemented with hormones and 
growth factors 26.To achieve cell culture conditions avoiding ascorbate contamination derived 
from animal sera, Hela cells were adapted to a chemically defined medium free of ascorbate for 
at least 2 weeks. Control cells were grown in the same medium supplemented with 50 μM 
ascorbate. Both cell groups proliferated at the same rate with no differences noticed between 
ascorbate-free and supplemented cells (Fig. 1A). Despite its need for PHD activity in vitro, 
hypoxic HIF-1α protein accumulation was similar in ascorbate containing and deficient cells. 
However, a faint normoxic induction of HIF-1α could be observed in ascorbate-free cells only 
(Fig. 1B). Accordingly, cells transfected with a HIF-responsive reporter gene (pH3SVL) and 
subsequently exposed to graded oxygen concentrations (0.2, 1, 3 or 21% O2, respectively) 
revealed similar induction levels of luciferase activity under both culture conditions (Fig. 1C).  
 
GSH can substitute for vitamin C in the hydroxylation reaction catalyzed by PHDs. 
Because HeLa cells grown in a medium containing no ascorbate maintained hypoxic HIF-1α 
stabilization, we speculated that other antioxidants could compensate for vitamin C loss in these 
cells. Thus, a number of compounds with antioxidative properties were tested for their effects on 
PHD hydroxylation activity using a previously described in vitro hydroxylation assay 23. 
Surprisingly, some compounds such as n-propyl gallate16 and the superoxide dismutase mimetic 
Mn (III) tetrakis (1-methyl-4-pyridyl) porphyrin pentachloride (MnTMPyP) were potent 
inhibitors of PHD enzymes (Supplementary Fig. 1A). However, reduced L-γ-glutamyl-L-
cysteinyl-glycine (glutathione; GSH) enhanced HIFα hydroxylation by all three PHDs. Since the 
recombinant enzyme preparations in the initial experiments were expressed and purified as 
glutathione-S-transferase (GST) fusion proteins, we could not exclude interference of the tested 
antioxidants, particularly GSH, with the GST tag. Therefore, a PreScission protease cleavage site 
was engineered in between the two fusion partners. Chimeric GST.PHD and tag-free PHD 
enzymes showed comparable hydroxylation activity (Supplementary Fig. 1B). GSH increased 
the activity of all three untagged PHD isoforms, even in the complete absence of ascorbate (Fig. 
2A). Addition of GSH ("+5 mM" in Fig. 2B) to 2 mM ascorbate increased the reaction rate when 
compared with ascorbate alone (“control” in Fig. 2B), suggesting two independent reaction 
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modes of GSH, one replacing vitamin C and an additional one enhancing the reaction rate. Of 
note, only minor changes in ascorbate oxidation were found before and after one hour of PHD2-
mediated substrate hydroxylation (Fig. 2C). The minor decrease in reduced ascorbate was most 
likely due to air-dependent oxidation rather than enzymatic consumption since it was 
independent of the presence of the hydroxyl-acceptor substrate (Fig. 2C, right panel). In 
conclusion, as shown previously for collagen P4H 27, ascorbate is not consumed during coupled 
PHD-catalyzed hydroxylation reactions.  
 
GSH decreases HIF activity in CoCl2-treated hepatoma cells. In cell culture models, 
Co (II) and Ni (II) have been shown to substantially decrease cellular ascorbate content by 
catalyzing ascorbate oxidation to DHA followed by irreversible hydrolysis to diketogulonate 28. 
Interestingly, exogenous ascorbate administration completely blunted the Co (II) induced 
hypoxic response in lung epithelial cells 29. To test if GSH could similarly compensate for 
reduced ascorbate levels after Co (II) stimulation, HIF transcriptional activity was further studied 
in HepG2 hepatoma cells stably transfected with a HIF-dependent luciferase reporter gene 
(HRG1 cells). We first determined the concentrations of CoCl2 required to activate HIF-
dependent reporter gene expression to a similar extent as exposure of the cells to 2% oxygen or 
the hypoxia mimicking iron chelator desferrioxamine (Dfx; Fig. 3A). Subsequently, HRG1 cells 
were treated with 100 μM CoCl2 or 50 μM Dfx under 21% or 2% oxygen. Control cells were 
kept at ambient oxygen concentrations. All cells were co-treated with 1-10 mM GSH or 0.2-2 
mM ascorbate. Indeed, ascorbate and GSH reduced HIF activity exclusively in CoCl2-treated 
HRG1 cells (Fig. 3B). A substantial increase of HIF activation was noted particularly when cells 
were treated with 2 mM ascorbate, which might be explained by the pro-oxidative function 
ascorbate exerts if applied at high concentration (Fig. 3B, upper panel) 30. In line with these 
observations, both ascorbate and GSH reduced the expression levels of the endogenous HIF 
target genes CA9 and NDRG1 3 only in cells treated with CoCl2, whereas 2 mM ascorbate 
enhanced hypoxic activation of both genes by almost 2-fold (Fig. 3C). To evaluate if these 
effects reflected differential activities of cellular PHD enzymes, HIF-1α protein accumulation 
was analyzed by immunoblotting. As expected, only CoCl2-stabilized HIF-1α was down-
regulated by co-treatment with ascorbate or GSH (Fig. 3D). Interestingly, 10 mM GSH was a 
more potent inhibitor of CoCl2-induced HIF-1α stabilization than 2 mM ascorbate, a 
 For personal use only. at UNIVERSITAETSSPITAL on March 11, 2011. www.bloodjournal.orgFrom 
  11
concentration which showed saturated inhibition of the HIF-reporter in the same cell line (Fig. 
3B, upper panel)  
 
GSH protects PHD2 from metal-catalyzed oxidation. Enzymatic activity of the PHDs 
is sensitive to reactive oxygen species (ROS) and transition metal ions 31. However, the 
mechanism(s) by which ROS or metal ions inhibit hydroxylase activity remained speculative. 
Besides its general antioxidative properties as radical scavenger, vitamin C actively interferes 
with the oxidation state of metal ions by serving as electron donor in a redox reaction. As such it 
largely differs from GSH which is a major cellular antioxidant protecting cysteinyl and 
methionyl residues in proteins from oxidative modifications. Both, CoCl2 and H2O2 inhibited all 
three PHD isoforms in vitro with PHD2 being slightly more resistant to CoCl2 (Supplementary 
Fig. 3). To directly determine protein oxidation by these compounds, carbonyl group formation 
in PHD2 was estimated by Oxyblot technology. As shown in Fig. 3E (left panel), 2 mM 
ascorbate and 10 μM FeSO4 (as used in the standard reaction buffer for in vitro hydroxylation) 
substantially increased carbonylation of recombinant PHD2 during one hour of hydroxylation 
reaction. Surprisingly, CoCl2 increased carbonylation of PHD2 whether ascorbate/FeSO4 was 
present or not. Following addition of 5 mM GSH, oxidation of PHD2 by ascorbate/FeSO4, CoCl2 
and H2O2 was markedly reduced. To examine whether PHD2 protein oxidation is coupled to its 
di-oxygenase activity, the reaction was performed in the presence of a mutant P564A HIF-1α 
peptide substrate. As shown in Fig. 3E (right panel), PHD2 protein oxidation was independent of 
the presence of a hydroxylation acceptor proline, providing evidence that protein oxidation is not 
caused by the hydroxylation reaction cycle. 
 
Cysteine 201 affects PHD2 hydroxylation activity. Recently, cysteine residue C201 
within the catalytic domain of PHD2 has been identified as a surface accessible, highly 
nucleophilic residue predominantly interacting with thiol compounds 32. Moreover, C201 and 
C208 were proposed to provide an additional metal binding site in PHD2 33. Both, C201 and 
C208 are highly conserved among all three human and mouse PHD isoforms (Fig. 4A). To 
investigate the functional relevance of C201, recombinant PHD2, wild-type or C201S mutant, 
was purified from Sf9 cells. Surprisingly, the C201S mutation significantly (p<0.0001) increased 
the PHD2 reaction rate by 2.5-fold (Fig. 4B, upper panel). Equal concentrations of wild-type and 
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mutant PHD2 proteins were confirmed by Coomassie staining of the undiluted stock solutions 
and immunoblotting of the diluted assay solutions (Fig. 4B, lower panel). To further test the 
hypothesis that the C201S mutation might protect the PHD2 enzyme from oxidative damage, the 
effect of H2O2 on hydroxylation activity was measured. As shown in Fig. 4C, the half-maximal 
inhibitory concentration (IC50) for H2O2 was roughly 5-fold higher for the C201S mutant 
compared with wild-type PHD2 (IC50 of 8.9×10-6 and 4.3×10-5 M H2O2 for wild-type and C201S 
mutant PHD2, respectively). We further tested if the H2O2 mediated loss of PHD2 activity could 
be rescued by sequential addition of GSH. For both enzyme preparations, pre-incubation with 1 
mM H2O2 for 30 minutes inhibited subsequent substrate hydroxylation reactions, inspite of 2 
mM ascorbate being freshly added to start the hydroxylation reaction (Fig 4D). Interestingly, 
further addition of 5 mM GSH could similarly reactivate both enzyme preparations, though 
reaction kinetics were substantially slower for the reactivated enzymes. (Fig 4D). 
 
Oxygen sensing is fully functional in ascorbate-deficient Gulo-/- mice. Gulo-/- mice 
received a diet with or without vitamin C for 5 weeks. Transcript levels of known HIF target 
genes (Bnip3, Ca9, Glut1, Pdk1, Phd2, Phd3, Ndrg1) as well as genes involved in antioxidative 
defense (Sod1, Sod2, Glrx), the ascorbate transporters Svct1 and Svct2 or oxygen-independent 
genes (Ednrb, Mmp3, Phd1) were determined by RT-qPCR in brain, lung, kidney, heart and 
liver. Similar tissue-specific expression levels for most genes involved in different pathways 
were observed in both groups (Fig. 5A). Conclusive with our finding from cell culture 
experiments, expression levels of most of the HIF target genes remained largely unaffected by 
vitamin C deficiency or even showed reduced levels (blank and blue squares, respectively, in the 
heatmap shown in Fig. 5B). Expression of the ascorbate transporter Svct1, however, was 
moderately induced in animals fed without ascorbate, possibly reflecting compensatory 
mechanisms for ascorbate deprivation. 
To further test if the absence of ascorbate limits PHD function under hypoxic conditions, 
Gulo-/- males were deprived from vitamin C for 5 weeks, while control animals were 
supplemented with vitamin C. As described previously 18, the animals developed a scorbutic 
phenotype marked by a substantial loss of body weight after 35 days on a ascorbate-free diet, 
indicating that systemic stores of vitamin C have been exhausted (Fig. 5C, left panel). In line 
with this observation, plasma ascorbate levels in Gulo-/- mice fed an ascorbate-free diet were 
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below the detection limit (≤1 μM), while plasma of control animals contained 40.3-123.8 μM of 
vitamin C (Fig. 5C, right panel), corresponding to ascorbate plasma levels in healthy humans 34.  
 Following 5 weeks of vitamin C deprivation, mice were breathing 8% oxygen for an 
additional period of 24 hours while control groups were kept under ambient oxygen 
concentration (see scheme in Fig. 5C). Both ascorbate-deficient and supplemented animals 
responded to the hypoxic treatment with a robust induction of Epo mRNA in the kidney which 
was higher in Gulo-/- males fed without ascorbate, though differences did not reach the level of 
significance (p = 0.07, Student’s t-test) (Fig. 5D, left panel). Circulating EPO protein levels in 
mouse plasma were induced by hypoxic exposure to a similar extent in both groups (Fig. 5C, 
right panel). Of note, no significant changes of the red cell lineage hematologic parameters were 
observed in Gulo-/- mice after 5 weeks of ascorbate depletion, indicating that the oxygen 
transport capacity was similar in both treatment groups. Hypoxic increases in hematocrit values 
are known to be delayed and reach the level of significance not before 72 hours of continuous 
exposure to hypoxia 35, explaining the lack of an increase of either hematocrit values or red 
blood cell counts in our experimental setting with a hypoxic period of only 24 hours 
(Supplementary Table 2). 
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Discussion 
Ascorbic acid and ferrous iron have been reported as essential co-factors for PHD-dependent 
HIFα hydroxylation in vitro 13. Unexpectedly, we found a fully functional cellular oxygen 
sensing pathway in HeLa cells maintained under strictly ascorbate-free culture conditions, 
indicating that ascorbate is dispensable for HIFα hydroxylation in vivo. In search for the nature 
of antioxidative compounds substituting for ascorbate during prolyl-4-hydroxylation, we 
identified GSH as a potent activator of all three PHDs in vitro, increasing HIFα peptide 
hydroxylation in a dose-dependent manner. Notably, ascorbate and reduced glutathione are the 
most abundant reducing compounds within eukaryotic cells 36. Given the distinct antioxidative 
properties of vitamin C and GSH, the two compounds might affect prolyl-4-hydroxylation by 
different ways. Ascorbate might be required to reduce occasionally oxidized ferric Fe (III) 
generated in the active centre of PHDs by uncoupled reaction cycles as it has been described for 
collagen P4H 27. However, to the best of our knowledge, no experimental evidence has been 
reported for enzymatic activity of PHDs in the absence of a hydroxyl-acceptor substrate. 
Strikingly, the major iron form bound to purified PHD2 is ferrous Fe (II) even when purified 
under oxygenated conditions 37, arguing against an essential role of ascorbate in reducing PHD 
iron. In support of this notion, iron and 2-oxoglutarate have been reported to co-purify with 50% 
and 5-10% of PHD2, respectively, while ascorbate did not co-purify at all 37. Recent work by 
Flashman et al. showed that ascorbate does not directly interact with the catalytic domain of 
PHD2, however, its intrinsic ene-diol reducing moiety was found to be important to promote 
hydroxylation by PHD2 38.  
GSH fully stimulated in vitro PHD hydroxylation activity only at rather high 
concentrations, which is in line with findings previously reported for N-terminally truncated 
PHD2 38. The millimolar GSH concentrations used in our study reflect physiologically relevant 
levels of this compound like they occur in living cells 39. Moreover, we found that ascorbic acid 
is not consumed by coupled substrate hydroxylation, suggesting that exogenously added GSH 
does not simply regenerate potentially co-purified oxidized dehydroascorbate (DHA). Our data 
rather favor an alternative function of GSH by preventing oxidative damage to the enzyme itself. 
Physiological concentrations of GSH were able to reduce transition metal- or peroxide-induced 
PHD enzyme carbonylation. Despite being generally referred to as antioxidant, ascorbate, 
together with oxygen and transition metals such as Fe (III) or Cu (II), also exerts pro-oxidative 
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effects by generating hydroxyl radicals in a Fenton-like reaction 40. Indeed, we found increased 
PHD2 carbonylation by ascorbate/iron in vitro, suggesting that GSH might protect PHDs from 
the adverse effects of ascorbate. In line with two distinct reaction modes, addition of GSH to 
hydroxylation reactions containing saturating ascorbate concentrations markedly increased the 
hydroxylation rate of PHDs in vitro. Of note, Co (II) induced ascorbate depletion, as suggested 
for cultured cells 28,29, cannot account for PHD inhibition in our cell-free assays, since we 
previously showed that Co (II) only inefficiently catalyses ascorbate oxidation by air under these 
assay conditions 16. Direct interference of Co (II) with the enzymes is supported by the 
observation that Co (II) strongly carbonylated purified PHD2 even in the complete absence of 
ascorbate. Moreover, ascorbate and GSH exclusively blunted Co (II)-induced HIF activation in 
our cellular models, demonstrating a complementary function of GSH and ascorbate in oxygen 
sensing by living cells. While simple chelation of Co (II) by ascorbate and GSH cannot be fully 
excluded in cell culture experiments, it should be mentioned that metal chelators naturally 
occurring in serum (e.g. histidine, glutamic acid, albumin but also GSH) are essential to facilitate 
Co (II) induced ascorbate oxidation, since “free” Co (II) is unable to directly oxidize ascorbate in 
simple aqueous solutions at neutral pH (reviewed in 28). Thus, the actual redox potential of the 
ion in such ternery complexes - rather than the intracellular concentration of “free” metal - 
determines its efficacy to act as a “hypoxia mimetic”.  
One of the specific GSH functions is to prevent or reduce inappropriate disulfide bond 
formation. Two recent reports identified PHD2 cysteinyl residues C201 and C208 to be highly 
nucleophilic and surface accessible 32,33. Moreover, crystallographic analyses predicted that these 
two cysteines might form disulfide bonds 32,33. C201S mutation protects recombinant PHD2 from 
oxidative damage in vitro and results in a 2.5-fold higher specific hydroxylation activity. One 
might speculate that a certain fraction of wild-type PHD2 enzyme constantly undergoes 
oxidative modification of C201, leading to reduced activity. As such, PHD enzymes could 
combine oxygen and redox sensing properties, providing a possible explanation for previous 
work on redox factors modulating PHD activity 41-43. However, potentiation of PHD activity by 
GSH clearly involves mechanisms distinct from C201 oxidation, since both, wildtype and C201S 
mutated PHD2 enzymes could be efficiently reactivated from H2O2-induced damage by GSH.  
Translating our biochemical and cellular findings in a systemic context, we did not 
observe marked alterations in HIF target gene expression following dietary vitamin C 
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deprivation in Gulo-/- mice, providing evidence that other antioxidants might substitute for 
vitamin C in vivo. Accordingly, the hypoxic response of Gulo-/- mice with low or undetectable 
ascorbate in the plasma was similar to mice receiving an ascorbate-supplemented diet. Consistent 
with antioxidant redundancy in vivo, a study using the same animals backcrossed to a BALB/c 
genetic background found vitamin C-independent de novo synthesis of collagen in allografted 
tumors and unchanged levels of hydroxyproline-collagen. Dermal hydroxyproline content of 
collagen was even increased 44. Of note, treatment of vitamin C-deprived guinea pigs with a cell 
permeable GSH monoethyl ester significantly attenuated the severity of scurvy-related 
symptoms, suggesting a cooperative function of both antioxidants for P4H function also in vivo 
45
. Moreover, Gulo-/- mice have increased levels of total glutathione in brain and liver, possibly 
explained by a compensatory mechanism for antioxidative defense in these animals 46.  
Interestingly, tumor growth and angiogenesis was retarded in a syngenic tumor model 
using vitamin C-deprived Gulo-/- mice, but no changes were observed for HIF-1α protein levels 
in the respective tumor tissue 47. The possible value of vitamin C in cancer therapy recently 
experienced a renaissance, since it has been shown that pharmacological doses of vitamin C 
decrease growth of tumor xenografts in mice by increasing peroxide levels in neoplastic tissue 
30,48
. Such tumoricidal effects of antioxidants might, at least partially, involve destabilization of 
HIFα following increased hydroxylase activity 49,50. Our data support a model of cooperative 
function of GSH and vitamin C in regulating the efficiency of PHD oxygen sensors. Translated 
to chemotherapy of cancers, combined treatment with both clinically approved molecules might 
even boost their antitumorigenic function.  
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Figure legends 
 
Fig 1. Cellular oxygen sensing by the PHD/HIF pathway does not require vitamin C. (A) 
Proliferation of HeLa cells growing in FCS-free, chemically defined medium containing either 
no or 50 µM ascorbate. (B) Stabilization of HIF-1α protein in HeLa cells maintained in FCS-free 
medium containing either no (-Asc.) or 50 µM ascorbate. Cells were exposed to 21 and 0.2% 
oxygen for 6 hours and protein levels analysed by immunoblotting. (C) Induction of HIF-
dependent luciferase activity (pH3SVL vector) in HeLa cells maintained in FCS-free medium 
containing either no or 50 µM ascorbate and exposed to 0.2%-21 % oxygen for 24 hours. 
 
Fig. 2. GSH substitutes for vitamin C as a co-factor in HIF-α hydroxylation in vitro. (A) 
GSH can enhance PHD hydroxylation activity in the absence of ascorbate (-Asc.) in a dose-
dependent manner. Hydroxylation activity was determined using a multi-well VBC binding 
assay. (B) PHD-dependent hydroxylation reaction rate in the presence of 2 mM ascorbate 
(control) or 2 mM ascorbate combined with 5 mM GSH (+5 mM GSH). Shown are mean values 
± SEM of triplicates. (C) Ascorbate determination by HPLC before and after 1 hour of PHD2-
dependent hydroxylation reaction (left panels). Ascorbate content is only slightly decreased after 
1 hour of incubation and independent of target hydroxylation (right panel). Shown are mean 
values ± SEM of three independent experiments normalized to values measured at time point 
zero. 
 
Fig. 3. GSH impairs HIF activation in cells. (A) Induction of HIF-dependent luciferase 
reporter gene activity in stably transfected HRG1 hepatoma cells by 2% O2, 50 μM Dfx or 100 
μM CoCl2 for 24 hours. (B) Effects of ascorbate (Asc, 0.2-2 mM; upper panel) or GSH (1-10 
mM; lower panel) in combination with hypoxia, Dfx or CoCl2 treatment on HIF-dependent 
luciferase activity relative to the protein concentration of the lysates. Shown are mean values ± 
SEM of three independent experiments normalized to the reporter activity in the absence of 
either ascorbate or GSH (control). (C) CA9 and NDRG1 HIF target gene mRNA levels in HRG1 
cells following treatment with 2 mM ascorbate or 10 mM GSH combined with 2% O2 or 100 μM 
CoCl2 for 24 hours. Shown are mean values ± SEM of three independent experiments relative to 
the mRNA content of ribosomal protein L28. (D) HIF-1α and CA9 protein levels in HRG1 cells 
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following treatment with 2 mM ascorbate or 10 mM GSH combined with 2% O2 or 100 µM 
CoCl2. (E) Oxyblot analyses of recombinant PHD2 protein carbonylation. GSH (5 mM) reduced 
PHD2 carbonylation by either 2 mM ascorbate/10 μM FeSO4 or 100 μM CoCl2 (left panel). 
PHD2 oxidation is independent of target hydroxylation as shown by using a wild-type or a 
P564A mutant HIF-1α hydroxyl-proline acceptor peptide in in vitro hydroxylation reactions 
(right panel). 
 
Fig. 4. A C201S mutation enhances PHD2-dependent hydroxylation reaction rate and 
protects from protein oxidation. (A) Conservation of cysteine residues (C201 and C208 in 
human PHD2) in all three human (Hs) and mouse (Mm) PHD isoforms. (B) Increased reaction 
rate of C201S mutant PHD2 as measured by the hydroxylation-dependent VBC binding assay. 
Shown are mean values ± SEM of three independent experiments. Linear regression analyses 
were performed, revealing highly different slopes (p<0.0001). (C) The C201S mutation confers 
resistance of PHD2 to H2O2-mediated inhibition of hydroxylation activity. Shown are mean 
values ± SEM of a representative experiment performed in triplicates. (D) Reduced glutathione 
(GSH) can rescue PHD2 wt and C201S hydroxylation activities after H2O2 -mediated enzyme 
damage. Briefly, enzyme preparations were pre-incubated with 1 mM H2O2 for 30 minutes 
(H2O2) or left untreated for a similar period (control). For rescue experiments, enzymes after 
H2O2 treatment were incubated with 5 mM GSH (H2O2+GSH) for 15 minutes. Hydroxylation 
reactions were carried out at standard assay conditions for 60 minutes. Note that all reactions 
contained 2 mM ascorbate freshly added when hydroxylation reactions were started. Data is 
given as mean values ± SEM of three independent experiments normalized to hydroxylation 
activities of control reactions obtained after 60 minutes. 
 
Fig. 5. The hypoxic response is fully functional in vitamin C depleted Gulo-/- mice. Gulo-/- 
male mice received a diet with (+Asc) or without (-Asc) ascorbate for five weeks. (A) Transcript 
levels of HIF target genes (Bnip3, Ca9, Glut1, Pdk1, Phd2, Phd2, Phd3, Ndrg1) as well as genes 
involved in antioxidative defense (Sod1, Sod2, Glrx), the ascorbate transporters Svct1 and Svct2 
or oxygen-independent genes (Ednrb, Mmp3, Phd1) were quantified by RT-qPCR in brain, 
kidney, lung, liver and heart. Values are expressed relative to S12 mRNA levels and visualized 
in a heat map (Genepattern, Broad Institute, USA). Lowest and highest mRNA levels of each 
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gene were arbitrarily defined as -3 (dark blue) and +3 (dark red), respectively. (B) Heat map of 
gene expression changes following a vitamin-C-deficient diet. Log2 (-Asc/+Asc) ratios revealed 
that the majority of HIF target genes remained either unchanged or showed a slightly reduced 
expression pattern. Data ranged from -1.75 (dark blue) and +1.79 (dark red), respectively. (C) 
Scheme depicting the experimental setup for hypoxic experiments with vitamin C depleted Gulo-
/-
 animals (upper panel). Relative gain of body weight of Gulo-/- mice (n=11 animals per group) 
following ascorbate withdrawal (-Asc) or ascorbate supplementation (+Asc) for 36 days (left 
panel). Ascorbate levels in the plasma of Gulo-/- mice (n=6 animals per group) after five weeks 
of ascorbate withdrawal compared to mice kept on an ascorbate-supplemented diet (right panel). 
(D) Epo mRNA (left panel) and circulating EPO protein (right panel) levels in Gulo-/- mice 
maintained on a diet with (+Asc) or without (-Asc) for five weeks followed by exposure to 8% or 
21% oxygen for 24 hours. Data represent mean values ± SEM derived from at least 5 animals per 
group (n.s., not significant). 
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